Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Channelrhodopsins are a subfamily of retinylidene proteins that function as light-gated ion channels. When expressed in cells, channelrhodopsins enable optical control over cellular excitability and physiological processes, making them foundational tools for optogenetics. Upon illumination, they open an ion-conducting pore across the membrane, leading to either depolarization (excitation) or hyperpolarization (inhibition) depending on the ion selectivity of the channel variant.
Light-gated ion channel activation leading to depolarization or hyperpolarization of cells.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Channelrhodopsin (ChR).